CF
MESO

Cantor Fitzgerald’s Mesoblast MESO Stock Holding History

Cantor Fitzgerald’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,147
Closed -$111K – 478
2025
Q2 		$111K Buy
+10,147
New +$114K ﹤0.01% 348
2024
Q3 		– Sell
-16,195
Closed -$110K – 267
2024
Q2 		$110K Buy
+16,195
New +$111K 0.02% 159

Other funds holding MESO

Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Cantor Fitzgerald's MESO Position: Q3 2025 in Review

Cantor Fitzgerald sold out of Mesoblast (MESO) in Q3 2025, closing a stake of 10,147 shares — an estimated $111K sold.

Cantor Fitzgerald first reported a position in MESO in Q2 2024 and held it in 2 quarters. The position peaked at $111K in Q2 2025. 68 funds tracked by Wall St. Rank hold MESO as of Q3 2025.

  • Cantor Fitzgerald reported no remaining Mesoblast position as of Q3 2025 after selling out during the quarter.
  • Cantor Fitzgerald sold 10,147 Mesoblast shares in Q3 2025, an estimated $111K.
  • Cantor Fitzgerald first reported a position in Mesoblast in Q2 2024 and held it in 2 quarters.
  • Cantor Fitzgerald's Mesoblast position peaked at $111K in Q2 2025.
  • 68 funds tracked by Wall St. Rank held Mesoblast as of Q3 2025.

Based on Cantor Fitzgerald's 13F filing for Q3 2025, filed 14 Nov 2025.